Teens Are Being Prescribed Wegovy and GLP-1s at Record Rates. Should Parents Be Worried?
It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
KEY BUSINESS HIGHLIGHTS Phase 2a clinical trial for Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease expected to begin Q1-2025.New Obesity, Metabolic & Inflammatory Disease ...
Ministers urged to abandon gimmicks in tackling NHS obesity costs as shock report released
Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.
kffhealthnews22h
Semaglutide Appears To Aid People With Alcohol Use Disorder, Study Says
Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.
What happens when you quit Ozempic? New study sheds light
A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.